Compounds > 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Asymptomatic Conditions

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Asymptomatic Conditions in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khakimova, GR1
Kozina, EA1
Buneeva, OA1
Aksenova, LN1
Medvedev, AE1
Ugryumov, MV1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Asymptomatic Conditions

ArticleYear
Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice.
    Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Asymptomatic Diseases; Corpus Striatum; Male;

2015